| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |